Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
DGX
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
-4.96%
$219.72-11.46Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$29.40B
52W Range
$197.81 - $495.55
DGX
Quest Diagnostics Incorporated
+0.93%
$233.24+2.15Delayed quote: Oct 2, 2026, 3:59 PM EDT
Market Cap
$25.74B
52W Range
$171.18 - $248.84
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 37.11 | 24.76 |
| Forward P/E | 32.95 | 20.84 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 21.71 | 3.43 |
| P/S Ratio | 6.12 | 2.23 |
| P/FCF Ratio | 54.19 | 21.10 |
| EV/EBITDA | 27.47 | 15.77 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 33.1% |
| Operating Margin | 20.8% | 14.1% |
| Net Margin | 16.8% | 9.2% |
| ROE | 59.7% | 14.1% |
| ROA | 14.5% | 6.3% |
| ROIC | 24.7% | 8.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 1.59 |
| Quick Ratio | 2.99 | 1.46 |
| Debt/Equity | 0.94 | 0.85 |
| Interest Coverage | 1.99 | 5.79 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 1.1% |
| Payout Ratio | N/A | 26.8% |
| Yrs of Dividend Growth | 0 | 14 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.